New research suggests that calming the brain's immune cells might prevent or lessen the damaging inflammation seen in ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

New research suggests that calming the brain's immune cells might prevent or lessen the damaging inflammation seen in ...

But the exact mechanisms of how the drug works in the brain in doing things like tamping down food noise, addiction, and now, ...

A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

Getting therapeutic drugs past the blood-brain barrier has long been one of medicine's most difficult challenges, limiting ...

A comprehensive review explores how gut microbiota diversity and fitness influence Alzheimer’s disease (AD) risk through ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

Brain and body don’t age ... explained that: “GLP-1 receptor antagonists and SGLT-2 inhibitors have been demonstrated to ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Alzheimer’s disease is notorious for robbing individuals of memory and cognitive function. Researchers have struggled for ...